Status:

COMPLETED

Remimazolam and Postoperative Nausea and Vomiting in High-risk Patients

Lead Sponsor:

Peking University First Hospital

Conditions:

Postoperative Nausea and Vomiting

Benzodiazepine

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This trial aims to explore whether the intraoperative use of remimazolam can reduce the incidence of postoperative nausea and vomiting (PONV) in high-risk patients. According to the Apfel's simplified...

Detailed Description

Postoperative nausea and vomiting (PONV) is a common adverse event after general anesthesia. The incidence of PONV within 2 hours after surgery was approximately 14% in patients undergoing laparoscopi...

Eligibility Criteria

Inclusion

  • Age ≥18 years old;
  • Scheduled to undergo elective surgery under general anesthesia;
  • Judged to be at high risk of postoperative nausea and vomiting. According to the Apfel's simplified score, patients with 3 or more of the following factors are at high-risk: women, non-smokers, history of PONV, postoperative use of opioids.

Exclusion

  • Refuse to participate;
  • Previous history of schizophrenia, epilepsy, Parkinson's disease or myasthenia gravis;
  • Severe liver dysfunction (Child-Pugh class C);
  • Severe renal dysfunction (dialysis required);
  • Patients of the American Society of Anesthesiologists (ASA) grade 4 and above;
  • Emergency surgery;
  • Continuously taking benzodiazepines for more than 1 week before surgery;
  • Any other circumstances that are considered unsuitable for study participation by attending physicians or investigators.

Key Trial Info

Start Date :

May 19 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 22 2023

Estimated Enrollment :

552 Patients enrolled

Trial Details

Trial ID

NCT04861337

Start Date

May 19 2021

End Date

April 22 2023

Last Update

January 3 2024

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

Peking University First Hospital

Beijing, Beijing Municipality, China, 100034

2

Beijing Hospital of the Ministry of Health

Beijing, Beijing Municipality, China

3

Beijing YouAn Hospital, Capital Medical University

Beijing, Beijing Municipality, China

4

Fuwai Hospital Chinese Academy of Medical Sciences

Beijing, Beijing Municipality, China

Remimazolam and Postoperative Nausea and Vomiting in High-risk Patients | DecenTrialz